New toolkit aims to boost HIV prevention in african american women

NCT ID NCT05139069

Completed Prevention Sponsor: Johns Hopkins Bloomberg School of Public Health Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a special toolkit designed to help African American women at risk for HIV get access to PrEP (a daily pill that prevents HIV). The toolkit also addresses intimate partner violence, which can make it harder for women to seek prevention. Researchers worked with two clinics in Mississippi and enrolled 27 healthcare providers to see if the toolkit increased PrEP prescriptions and follow-up visits.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Trauma-Informed Toolkit (behavioral intervention)
What this could lead to: If successful, this toolkit could help more African American women access HIV prevention medication, especially those facing intimate partner violence.
What could go wrong: This was a small pilot study with only 27 participants, so results may not apply broadly. The toolkit is behavioral, not a drug, so its impact on HIV rates is indirect.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DOMESTIC VIOLENCE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

HIV infectious disease prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DOMESTIC VIOLENCE HIV INFECTIONS

Contacts and locations

Locations

Johns Hopkins Bloomberg School of Public Health

Baltimore, Maryland, 21220, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.